Global Direct-to-consumer Disease Risk and Health Genetic Test Market - Size and Forecast Analysis, 2021-2035
Download Free Sample Report
Fill out the form below to receive a complimentary sample of this report. Our research team will deliver it to your inbox within 24 business hours.
Frequently Asked Questions
What is the scope of this report?
Global Direct-to-consumer Disease Risk and Health Genetic Test Market Size was valued at USD 5.23 Billion in 2024 and is projected to reach at USD 27.64 Billion in 2035.
What are the key market segments covered?
Global Direct-to-consumer Disease Risk and Health Genetic Test Market is expected to grow at a CAGR of around 16.33% during the forecasted year.
Which regions are covered in this report?
North America, Asia Pacific and Europe are major regions in the global Direct-to-consumer Disease Risk and Health Genetic Test Market.
Who are the key companies profiled?
Key players analyzed in the global Direct-to-consumer Disease Risk and Health Genetic Test Market are 23andMe; MyHeritage; LabCorp; Myriad Genetics; Ancestry.com; Quest Diagnostics; Gene By Gene; DNA Diagnostics Center; Invitae; IntelliGenetics; Ambry Genetics; Living DNA; EasyDNA; Pathway Genomics; Centrillion Technology; Xcode; Color Genomics; Anglia DNA Services; African Ancestry; Canadian DNA Services; DNA Family Check; Alpha Biolaboratories; Test Me DNA; 23 Mofang; Genetic Health; DNA Services of America; Shuwen Health Sciences; Mapmygenome; Full Genomes and so on.